4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000031
Chief Financial Officer gave up 1,599 shares (to pay taxes)
- Chief Financial Officer acquired 5,387 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hirsch Andrew · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-04-13 | Exercise or conversion : show line 1 in the form | +5,387 | 21,905 | D | ||
| 2020-04-14 | Shares withheld for taxes : show line 2 in the form | −1,599 | $40.64 | $64,983 | 20,306 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-04-13 | Exercise or conversion : show line 3 in the form Performance share units | −5,387 | 10,775 | D |
Loading xslF345X03/wf-form4_158698238335139.xml…